Search Results

Surgery lowers risks of death, heart disease, kidney failure, and eye damage more than GLP-1 medicines

More than half who took weight-loss drugs following bariatric surgery did so within four years.

While bariatric surgery offers hope for many battling obesity, the tragic death of a woman in Meerut raises urgent concerns about medical negligence and the responsibilities of healthcare providers.

Study finds bariatric surgery significantly reduces risk of chronic kidney disease progression compared to GLP-1 drugs in patients with obesity and diabetes

Seven months after Lahavah Wallace’s weight loss operation, a New York bariatric surgery practice sued her, accusing her of “intentionally” failing to pay nearly $18,000 of her bill.

Patients who are satisfied with their physicians are more likely to follow through with metabolic or bariatric surgery (MBS) regardless of racial or ethnic group, according to researchers.